Stopped: This study was never conducted due to Covid. Key informant interviews were conducted instead.
Over 27 million Americans are diagnosed with Type 2 Diabetes Mellitus (T2DM), and their health outcomes, including hospitalization, emergency department use, and hospital readmission, are largely driven by social determinants; diabetes complications are largely attributable to unmet health-related social needs. Investigators will conduct a pilot feasibility trial of the Re-Engineered Discharge for Diabetes-Computer Adaptive Testing (REDD-CAT) system to inform the design of a future, fully-powered randomized controlled trial. REDD-CAT will allow clinical staff to preemptively link patients with community-based social services tailored to meet their unique needs in order to reduce avoidable hospitalization and emergency department visits.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility - Recruitment potential: percentage of eligible patients willing to enroll in the study
Timeframe: 6 months
Feasibility - Participant burden: time required for participants to complete data collection measures
Timeframe: 6 months
Feasibility - Subject retention: percentage of patients who complete the 30-day follow-up time point
Timeframe: 30 days
Feasibility - Implementation fidelity: percentage of indicated referrals that are made
Timeframe: 30 days